Latest News

Full Year Trading Update & Notice of Final Results

Full Year Trading Update & Notice of Final Results

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, announces the following trading update for the year ended 31 January 2017.

Posted by: Quantum Webmaster on 1st February 2017

Appointment of Chief Financial Officer

Appointment of Chief Financial Officer

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, is pleased to announce the appointment of Gerard (Ged) Murray to the Board as Chief Financial…

Posted by: Quantum Webmaster on 8th December 2016

Appointment of Nominated Adviser

Appointment of Nominated Adviser

Quantum Pharma plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, announces the appointment of N+1 Singer as the Company's nominated adviser and sole broker with…

Posted by: Quantum Webmaster on 1st December 2016

Result of General Meeting and £15m fundraise

Result of General Meeting and £15m fundraise

Quantum Pharma Plc (AIM: QP.) the service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, announced on 20 October 2016 that the Company had raised a total of £15 million (before expenses)…

Posted by: Quantum Webmaster on 10th November 2016

Confirmation of successful £15 million fundraise subject to shareholder approval

Confirmation of successful £15 million fundraise subject to shareholder approval

Quantum Pharma Plc (AIM: QP.) is pleased to announce that, following the announcement made earlier today entitled “Proposed Accelerated Bookbuild to raise up to £15 million”, the Company has raised a total of £15…

Posted by: Quantum Webmaster on 20th October 2016

CEO appointment and Board Changes

CEO appointment and Board Changes

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, announces the following changes and proposed changes to its board of directors (the ‘Board&rsquo…

Posted by: Quantum Webmaster on 19th October 2016

Half year results for the six months to 31 July 2016

Half year results for the six months to 31 July 2016

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, has today published its half year results for the six months to 31 July 2016 ('H1-FY17' or the…

Posted by: Quantum Webmaster on 4th October 2016

Trading Update and Notice of Half Year Results

Trading Update and Notice of Half Year Results

Quantum Pharma Plc (AIM:QP.), the growing, service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, is pleased to announce its trading update for the half year ended 31 July 2016.

Posted by: Quantum Webmaster on 31st August 2016

Launch of Glycopyrronium Bromide Oral Solution

Launch of Glycopyrronium Bromide Oral Solution

Quantum Pharma Plc (AIM:QP.), the growing, service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, is pleased to announce that Colonis Pharma Limited (“Colonis”), part of the Group…

Posted by: Quantum Webmaster on 10th August 2016

Launch of Mucodis® Vaginal Cream

Launch of Mucodis® Vaginal Cream

Quantum Pharma Plc (AIM:QP.), the growing, service-led niche pharmaceutical developer, manufacturer and supplier to the health and care sectors, is pleased to announce that Colonis, part of the Group's Niche Pharmaceutical division…

Posted by: Quantum Webmaster on 5th August 2016